Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Subscribe
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Subscribe
FREE
Filter Content:
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Articles
Oncology
17 Nov 2014
Women and Lung Cancer: Literature Assumptions and News from Recent Publications
For a long period of time, lung cancer (LC) was considered as a malignancy affecting only males, but epidemiological data have shown a dramatic increase…
Oncology
17 Nov 2014
Rituximab and Other New Anti-CD20 MAbs for Non-Hodgkin’s Lymphoma Treatment
Non-Hodgkin’s lymphomas (NHLs) are a heterogeneous group of different haematological cancers with a wide range of aggressiveness. NHLs represent >80% of….
Oncology
17 Nov 2014
Fundamental Principles of Raising an Antitumour Immune Response in Vivo: A Complex Model, a Case Report, and a Perspective
In preclinical model systems, the fundamental principles underlying a successful and durable anti-tumour immune response are well demonstrated.
Oncology
17 Nov 2014
Immunotherapy of Cancer: Towards a New Era
In the past two decades, immunotherapy of cancer has developed into an established treatment option. At first, the development of monoclonal antibodies…
Oncology
17 Nov 2014
Radiotherapy for Breast Cancer: How Can it Benefit from Advancing Technology?
There have been significant technological and technical advances in radiotherapy over the last 20 years. This paper presents the pertinent advances and…
Oncology
17 Nov 2014
Management of Patients with High-Grade Glioma
The scientific basis for the surgical management of patients with glioma is rapidly evolving. The infiltrative nature of these cancers precludes a…
Oncology
17 Nov 2014
State-Of-The-Art Treatment in Castration-Resistant Prostate Cancer
Prostate cancer (PrCa) is the most common cancer type in men in developed countries. In the last few years, a dramatic change has occurred in the…
General Healthcare
3
Mins
5 Nov 2014
Limited Resources
Last week I had the opportunity to attend a small breakfast meeting where the speaker was Dr Catherine Mohr. Dr Mohr is an extraordinary individual…
Loading posts...
« Previous
1
…
224
225
226
227
228
…
257
Next »